{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-26-000019","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.923387+00:00","generated_at":"2026-05-15T22:07:08.180579+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Emergent BioSolutions appoints John D. Fowler, Jr. to board of directors effective March 1, 2026","bullets":["Fowler appointed as Class II director and will serve on the Audit and Finance Committee.","Receives initial RSU grant valued at $270,000 vesting in three equal annual installments.","Annual compensation: $70,000 cash retainer, $15,000 committee fee, $270,000 equity award (prorated first year).","Chairman Zsolt Harsanyi states Fowler's experience will support the company's ongoing turnaround and transformation.","Fowler brings 30+ years in healthcare and finance, including senior roles at Wells Fargo, Deutsche Bank, and JPMorgan."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-26-000019","json":"https://secwatch.observer/filing/0001367644-26-000019.json","markdown":"https://secwatch.observer/filing/0001367644-26-000019.md","text":"https://secwatch.observer/filing/0001367644-26-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764426000019/0001367644-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764426000019/ebs-20260225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:07:08.180579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}